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Clinical characteristics of children with 2009 
pandemic influenza A (H1N1) admitted to a single 
institution 
Purpose: This study aims to investigate the clinical characteristics of 
children diagnosed with the novel influenza A (H1N1) in the winter of 
2009 at a single medical institution.
Methods: Out of 545 confirmed cases of influenza A (H1N1) in 
children, using the real time RT-PCR method at Kosin University 
Gospel Hospital from September to December of 2009, 149 patients 
and their medical records were reviewed in terms of symptoms, 
laboratory findings, complications and transmission within a family.
Results: Median age of subjects was 7 years (range: 2 months-18 
years). New cases increased rapidly from September to reach a 
peak in November, then declined rapidly. Most frequently observed 
symptoms were fever (96.7%), cough (73.2%), rhinorrhea (36.9%) and 
sore throat (31.5%). Average body temperatures on the 1st, 2nd and 
3rd hospital day were 38.75±0.65℃, 38.08±0.87℃ and 37.51±0.76℃, 
respectively. Complete blood counts and biochemical tests performed 
on the first admission day showed within the reference values in most 
cases. Of the 82 patients with simple chest radiography, 18 (22%) had 
pneumonic lesions; multi-focal bronchopneumonia in eleven, single 
or multi-segmental lobar pneumonia in five, and diffuse interstitial 
pneumonia in two patients. All of the 149 patients improved from their 
symptoms and discharged within 9 days of admission without any late 
complication.
Conclusion: Children with 2009 pandemic influenza A (H1N1) at 
our single institution displayed nonspecific symptoms and laboratory 
findings, resembling those of common viral respiratory illnesses, and 
did not appear to develop more severe disease. 
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Introduction
In late March and early April 2009, an outbreak of influenza A 
(H1N1) infection was detected in Mexico. At first, it was called 
'swine influenza' but, subsequently the name was changed to 
influenza A (H1N1) by the WHO's recommendation. On June 
11, 2009, the WHO raised its pandemic alert level to the highest 
level, phase 6, indicating widespread community transmission 
throughout at least two continents
1). In Korea, as of January 19, 
2010, there have been 218 deaths in patients with laboratory-
confirmed influenza A (H1N1), since the first case was identified on 
May 2, 2009
2). 
High rates of infection, morbidity and mortality have been noted 
among children and young adults across the globe. About 78% of 
the patients with influenza A (H1N1) were younger than 30 years 
old
3) with the most reported cases in the age range of 14 to 20 years. 
In Korea, there was a rapid increase in the number of reported cases 
among children since the middle of October 2009
4).
The symptoms of influenza A (H1N1) were known not to 
be different from those of common viral respiratory illnesses 
or seasonal influenza, though the real-time RT-PCR test 
can differentiate between them. To investigate the clinical 
characteristics of children of the pandemic influenza in the winter 
of 2009, we reviewed the medical records of 149 children who had 
admitted to our institution.
Subjects and methods
1. Subjects
From September to December 2009, in Kosin University Gospel 
Hospital, 1,037 children under the 19 years of age presented with 
influenza like illness were tested for 2009 influenza A (H1N1) 
by real time reverse transcription-polymerase chain reaction (rt 
RT-PCR) method. Among them, 545 patients (52.6%) were 
confirmed. Only 149 patients (27.3%) of them were admitted to 
pediatric ward or cared at emergency room more than 6 hours, and 
their medical records were available to study symptoms, contact 
history with a confirmed case, and complications on follow-up. Of 
the 149 patients, 79 cases underwent laboratory exams including 
inflammatory indicators and chest radiograms, as they had been 
cared at pediatric ward more than 2 days. 
2. Methods 
1) Collection of specimen for diagnosis
Sterile swabs with cotton tips and wooden shafts were inserted 
into the oral cavity of the patients. The throat swab was rubbed on 
the tonsillar surface or the pharyngeal mucosa that presented the 
most secretion under visual inspection. The swab was removed 
from the mouth and the tip of the swab was carefully inserted into a 
bottle containing 1 ml of virus transport media. 
 
2) Real time RT-PCR assay
(1) Extraction of RNA and synthesis of cDNA
Respiratory specimens were put into the Abbott m2000sp 
automatic sample preparation machine (Abbott Molecular Inc., 
Des Plaines, Illinois, USA) and RNAs were extracted using the 
Abbott mTM sample preparation system. Viral RNA was reverse 
transcribed into complementary DNA (cDNA) using a swine-
lineage influenza A (H1N1) generic primer. The subsequent PCR 
amplification and real-time detection of cDNA are performed on 
Abbott’s m2000rt amplification machine.
(2) Used probes and condition for real-time RT-PCR 
Each RNA extract sample was tested by separate primer/probe 
sets: InfA, Universal swine (swFluA), Swine H1 (swH1) and 
RNaseP (RP). The RNaseP primer and probe set targets the human 
RNaseP gene and thus served as an internal positive control for 
human nucleic acid. 
3) Criteria of positive reaction 
The test for H1N1 influenza A virus is regarded positive if 
the specimen is positive to either swFluA or swH1 probe, with 
a concomitant positive reaction to both InfA and RNaseP (RP) 
probes.
4) Data collection
Medical charts of the patients who were confirmed as novel 
H1N1 influenza A under the age of 19 were reviewed in terms of 
demographic features, presenting symptoms, and risk factors for 
influenza. Fever was defined as a temperature of ≥37.8℃. Body 
temperature was measured mainly at the forehead or retroauricular 
area by feverscan (Thermofocus
®) and occasionally in the ear 
by infrared tympanic membrane temperature thermometer 
(Thermoscan
®PRO-LT, Thermoscan, Minnesota, USA). For 
patients who were admitted, studies of peripheral blood counts, 
erythrocyte sedimentation rate, serum aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), lactate dehydrogenase 
(LDH), high sensitivity C-reactive protein (HS-CRP), creatine 
phosphokinase and simple chest X-ray findings were analyzed. To 
gain additional information about complication or development 
of secondary patients within the households, a telephone call was 
given to each family. 888      SI Park, et al. • Clinical characteristics of children with 2009 influenza A (H1N1)
Result
1. Characteristics of the patients 
 The mean age of the 149 patients was 7.0 (±4.1) years with a 
range of 2 months to 18 years. Patients are most predominant in 
the age group of 6-18 years (n=91, 61.1%). Of the 149 patients, 
58 were younger than 6 years, and among the seven patients 
who had bronchial asthma 6 were in the age group of 6-18 years. 
Accordingly, the proportion of patients considered to belong to a 
'high risk group' based on age and underlying medical condition 
was 43.0% (64/149). 
During the 4 months period, there was 1 patient in September, 
and there were 41 in October 89 in November and 18 in December. 
So, the numbers of new patients increased rapidly from September 
to reach a peak in November, then declined rapidly (Fig. 1). 
23 (15.4%) of the 149 patients had close contact history with 
confirmed cases mostly from kindergarten or school (n=13), family 
(n=7) and their relatives (n=3). The remaining 126 (84.6%) had no 
known history of contact with confirmed cases.
2. Presenting symptoms and signs of the patients
Of the 149 patients, the most common symptom was fever 
(n=144, 96.7%). The next common symptoms were cough (n=109, 
73.2%), rhinorrhea (n=55, 36.9%), sore throat (n=47, 31.5%), 
headache (n=26, 17.4%) and sputum (n=21, 14.1%) in descending 
order of frequency. Other symptoms included were vomiting (n=13, 
8.7%), abdominal pain (n=11, 7.4%), dizziness (n=9, 6.1%), dyspnea 
(n=6, 4.0%), myalgia (n=5, 3.4%), chill (n=4, 2.7%), stuffiness 
(n=4, 2.7%), diarrhea (n=2, 1.3%), stridor (n=2, 1.3%), nausea (n=1, 
0.7%), convulsion (n=1, 0.7%), and skin rashes (n=1, 0.7%) (Fig. 
2). On physical examination of the 149 patients, injected tonsillar 
pharyngeal mucosa were noticed in 20 patients (13.4%), and rales 
or wheezings were present in 10 patients (6.7%).
3. Hematologic and biochemical laboratory findings
Of the 149 patients, 79 were admitted to pediatric ward, 
and a complete blood counts were made with peripheral blood. 
68 (86.1%) of them showed leukocyte count in the range of 
4,000×12,000/μ L, while 9 (11.4%) showed under 4,000/μ L and 2 
(2.5%) showed above 12,000/μ L. Patients had thrombocytopenia 
less than 150,000/μ L in 10.1% (8/79). ESR were increased above 
15 mm/hr in 17.7% (14/79). Serum levels of HS-CRP showed 
under the 0.75 mg/dL in 49.4%, between 0.75 to 5.0 mg/dL in 
36.7%, above 5.0 mg/dL in 13.9%. No patient showed serum 
levels of AST and ALT more than 100 IU/L. Serum levels of 
creatine phosphokinase were checked in 40 patients, and 12 (30%) 
of them had values more than the upper reference range of 130 U/
L (Table 2). 
4. Chest radiographic findings of the patients
Chest X-rays were performed in 82 patients at the time of 
admission or at first visit, Among them, 59 (72.0%) had normal 
Table 1. Distribution of 149 Patients by Age and Gender
Age  Male (%)  Female (%)  Total (%)
0-<6 mo 
6-<24 mo 
2-<6 yr 
6-18 yr 
Total
2  (  1.3) 
10 (  6.7) 
24 (16.1) 
52 (34.9) 
88 (59.1)
0  (  0   ) 
1  (  0.7)
21 (14.1)
39 (26.2) 
61 (40.9) 
2   ( 1.3)
11  (  7.4)
45  (30.2)
91 (61.1)
149 ( 100)
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Fig. 1. Monthly distribution of the 149 studied patients.
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Fig. 2. Presenting symptoms of the 149 patients. 
Table 2. Laboratory Findings of Admitted Patients 
Laboratory tests No. of patient Mean±SD  Range
WBC (×10³/μL) 
Hemoglobin (g/dL) 
Platelet (×10³/μL) 
ESR (mm/hr) 
HS-CRP (mg/dL) 
AST (IU/L) 
ALT (IU/L) 
LDH (IU/L) 
CK (IU/L) 
79
79
79
79
79
79
79
40
40
9.8±6.4 
13.0±1.1 
253.2±76.8
7.9±6.2 
2.7±3.2 
40.6±17.1
19.7±9.8 
445.9±78.0 
138.6±134.7 
3.3-23.8
11.1-14.4
77.0-347.0
2.0-22.0 
0.03-12.6
21.0-97.0 
12.0-55.0
360.0-574.0 
59.0-3,478.0 Korean J Pediatr 2010;53(10):886-891 • DOI: 10.3345/kjp.2010.53.10.886    889
findings, while 18 (22.0%) presented images compatible with 
pneumonia (Table 3). Those 18 cases were able to classify into three 
main radiographic patterns; multifocal bronchopneumonia (n=11), 
single or multisegmental lobar pneumonia  (n=5), and diffuse 
interstitial pneumonia (n=2). Two patients with lobar pneumonia 
associated with atelectasis and emphysema in one case, and pleural 
effusion in the other. 
5. Clinical course and intra-familial transmissibility 
Of the 149 patients, 79 (53.0%) were admitted and 70 (47.0%) 
were taken care of at emergency room for more than 6 hours. Only 
one patient with multi-segmental lobar pneumonia associated 
with atelectasis and emphysema required oxygen inhalation 
through facemask for a day on the first day of admission. None of 
the patients required mechanical ventilation or admission to an 
intensive care unit.
The average length of hospital stay of the patients was 4 days 
(range of 2-9 days). Body temperatures were available to monitor for 
4 consecutive days in 48 patients and 5 days in 30 patients. Average 
body temperatures on the 1st, 2nd, 3rd, 4th and 5th hospital day 
were 38.75±0.65℃, 38.08±0.87℃, 37.51±0.76℃, 37.00±0.63℃ 
and 36.85±0.61℃, respectively, showing rapid defervescence 
from the 3rd hospital day (Fig. 3). Distribution of documented 
temperatures of 77 patients upon initial visits were ≥40℃ in 2.6% 
(2/77), 39.0-39.9℃ in 40.2% (31/77), 38.0-38.9℃ in 44.2% 
(34/77) and < 38.0℃ in 13.0% (10/77). 
Most of the pneumonic lesions observed on chest radiographs of 
the 18 cases were undetectable within 9 days of admission. All of 
the 149 patients had no remaining symptoms or complications on 
follow up visits at OPD or according to telephone surveys. 
As two families had concurrent infections in their brothers, the 
rate of concurrent infection among the total 147 families was 1.4 
% (2/147). In sixteen families, twenty infected patients developed 
secondarily within the households. These 20 new patients were 
comprised of younger siblings (n=7, 35%), mothers (n=6, 30%), 
elder siblings (n=4, 20%) and fathers (n=3, 15%). The mean 
generation time or serial interval time (time from the onset of 
symptoms in the primary case until the onset of symptoms in 
a secondary case) was 3.4 (±0.7) days. Most of these data were 
collected by follow-up telephone interviews with their parents.  
Discussion
Annual morbidity due to influenza is highest in children, in 
whom the attack rates are often 30-50%
5). Recent studies have 
documented that infants and young children without underlying 
medical conditions are hospitalized for influenza-attributable 
illnesses at rates of 6-15%
6). Persons under the age of 30 years had 
little evidence of cross-reactive antibodies to the pandemic Influenza 
A (H1N1), whereas 39 of 115 persons (34%) born before 1950 had 
preexisting cross-reactive antibodies
7). Serologic studies of persons 
who received vaccination with seasonal influenza vaccines suggest 
that seasonal influenza vaccines will not provide protection against 
novel influenza A (H1N1) virus. Among adults, cross-reactive 
antibodies to novel influenza A (H1N1) virus at titers that correlate 
with protection from illness in studies of seasonal influenza vaccine 
was detected in 6-9% of those aged 18-64 years and in 33% of 
those aged >60 years
8). 
The above-mentioned facts might be the reason why novel 
influenza A (H1N1) is more common in young ages. The median 
and average age released from the study of people less than 18 years 
by the Korean CDC on October 29, 2009 was 7.5 and 8.9 years, 
respectively
2). In our institution, both of the median and average age 
of the patients were 7.0 years. 
The clinical diagnostic criteria may have similar diagnostic 
accuracy to that provided by the current rapid diagnostic tests. 
The criteria for the clinical diagnosis of influenza consists of a fever 
greater than 37.8℃ plus two or more URI symptoms (cough, sore 
throat, nasal symptoms, myalgia, headache, malaise)
9). Among our 
149 patients, 77 (51.6%) were compatible with these criteria. 
Several rapid antigen and immunofluorescent antibody tests 
Table 3. Classification of Chest X-ray Findings of Children with 2009 
Pandemic Influenza A (H1N1)
Chest X-ray Findings  n=82
Normal
Abnormal
Multi-focal bronchopneumonia
Single or multi-segmental lobar pneumonia 
Diffuse Interstitial pneumonia
64 (78%) 
18 (22%)
11
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Fig. 3. Changes in body temperature (average±standard deviation) 
during the first 4 hospital days in 48 patients and on the 5th day in 30 
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are available for the diagnosis of influenza virus infection. The 
sensitivity of these tests varies widely, and although some assays 
are able to distinguish between influenza A and B viruses, they are 
not able to distinguish between pandemic and seasonal strains of 
H1N1 influenza A. However, the specificity of these rapid antigen 
tests seems to be much higher compared to its sensitivity. In our 
survey, all positive cases for influenza A with rapid antigen test 
showed positive to rt RT-PCR tests, though the details are not 
presented here. Confirmation can be made only by rt RT-PCR or 
culture. Viral culture is too slow to help guide management, and a 
negative viral culture does not exclude pandemic H1N1 influenza 
A infection. 
The most common clinical symptoms surveyed in all age groups 
by Novel Swine-Origin Influenza A (H1N1) Virus Investigation 
Team in USA were fever (94%), cough (92%) and sore throat 
(66%). In addition, 25% of patients had diarrhea and 25% had 
vomiting
10). The two most common symptoms of fever (96.7%) and 
cough (73.2%) in our patients was not different from the WHO 
and CDC reports. However, the low frequencies of gastrointestinal 
symptoms and general symptoms such as chill, myalgia and 
malaise in our subjects need further investigation as to whether 
these symptoms are truly rare in children or may not be reported 
by young children and improperly recorded by physicians in a busy 
outpatient or emergency environment. 
The Center for Disease Control in Korea surveyed 2,417 patients 
with 2009 H1N1 influenza A from May to August 19, 2009. The 
most common clinical findings of the patients were cough (78.1%), 
fever (77.2%), sore throat (51.12%), rhinorrhea (46.0%), headache 
(37.4%), myalgia (23.6%), sputum (15.8%), nausea (9.8%), diarrhea 
(9.3%) and vomiting (5.3%). The average body temperature of the 
1,842 patients who had documented temperature upon initial visit 
was 38.1(±0.9)℃
11). Average body temperatures on the 1st, 2nd and 
3rd hospital days in our cases were 38.8±0.7℃, 38.1±0.9℃ and 
37.5±0.8℃, respectively. On a review of body temperatures of our 
77 patients 42.9% (33/77) had temperatures equal to or higher 
than 39.0℃. 
Laboratory tests including complete blood counts and bio-
chemical tests performed at the time of admission were found to 
fall within the reference values in most of our cases. The serum 
AST, ALT values were elevated very minimally in a few. One 
noticeable feature is that 6 of the 40 patients (15%) have values of 
serum creatine phosphokinase higher than 512 IU/L which could 
be attributed to accompanying rhabdomyositis, however, none of 
those patients was documented to have myalgia. One report from 
Mexico showed 10 of the 16 patients had increased creatine kinase 
levels (62%) and 5 of them had very high values ranging from 1,099 
to 5,122 IU/L
12).
Complications of the 2009 pandemic influenza A (H1N1) 
were not seem to be much different from those of other seasonal 
influenza. Children younger than 2 years old, adults 65 years of 
age or older, pregnant women, women up to 2 weeks postpartum 
and persons with certain medical conditions are regarded as high 
risk groups for severe complications
13). Some of these patients 
experienced a sudden and very rapid deterioration in their clinical 
condition, usually on day 5 or 6 following the onset of symptoms
14). 
Clinical deterioration is characterized by primary viral pneumonia, 
and failure of multiple organs including the heart, kidneys and liver. 
The CDC of the United States documented that children less 
than 6 years of age are at high risk of complications from in  fluenza
13). 
However, observation thereafter showed that children less than 
2 years of age had a significantly greater risk of hospitalization
14).   
Children taking long-term aspirin therapy or persons with blood 
disorders such as sickle cell disease or chronic neurological and 
neuromuscular disorders, neurodevelopmental condition or 
obesity also have increased risk of hospitalization or morbidity
9, 15, 
17). In our study, 64 out of 149 patients (43.0%) were classifiable as 
belonging to a 'high risk group'. Most of our patients showed rapid 
defervescence with an oral antiviral agent, oseltamivir (Tamiflu
®). 
In a small proportion of patients, the drug was not given because of 
mild symptom or discontinued because of vomiting. 
The mean time interval between infection of a primary case 
and one of its secondary cases (the mean generation time) of 2009 
pandemic influenza A (H1N1) was known to be 2.5-3.0 days
18). 
After close contact most patients presented symptom in 1-4 days
19) 
with mean incubation of 1.4 days, (95% CI: 1.0-1.8 days)
8, 18). The 
mean generation time within the households in our study was 3.4 
(±0.7) days.
Neurological long-term pulmonary complication or fatal course 
did not occur in our patients, however, the number of patients in 
our study was not enough to say that the 2009 influenza A virus, 
H1N1 subtype have without risk. Further study will elucidate the 
severity or epidemiology of the novel influenza A (H1N1) which is 
expected to continue to spread beyond pandemic.
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